Skip to content

Efficacy of Esmeprazole and Lansoprazole in patients with upper gastrointestinal symptpms taking non-steroida anti-inflammatory drugs

Efficacy of Esmeprazole and Lansoprazole in patients with upper gastrointestinal symptpms taking non-steroida anti-inflammatory drugs - Efficacy of Esmeprazole and Lansoprazole

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008736
Enrollment
400
Registered
2012-08-20
Start date
2012-08-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(1)continuous in use about NSAIDs aged 20 and over. (2) The patient who has an anamnesis of digestive ulcer. (3) The patient at least whose one item it is at the research registration time and is three or more points in the question item of a GOS interview sheet. (4) Those by whom the consent of research participation was got with the document.

Interventions

A group (Esomeprazole medication) Esomeprazole 20mg once before breakfast for 2weeks B group (Lansoprazole medication) groups. Lansoprazole 15mg once before breakfast for two weeks

Sponsors

Department of Orthopaedic Surgery Shimane University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) He is man and woman continuous in use about NSAIDs aged 20 and over. (2) The patient who has an anamnesis of digestive ulcer. (3) The patient at least whose one item it is at the research registration time and is three or more points in the question item of a GOS interview sheet. (4) Those by whom the consent of research participation was got with the document.

Exclusion criteria

Exclusion criteria: Except the above

Design outcomes

Primary

MeasureTime frame
Global Overall Symptom scale

Countries

Japan

Contacts

Public ContactYuji Uchio

Shimane University School of Medicine Department of Orthopaedic Surgery

uchio@med.shimane-u.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026